Professor of Immunology at the University of Navarra, CIMA researcher and co-director of the Department of Immunology and Immunotherapy at the Clínica Universidad de Navarra.
A pioneering phase 1 clinical trial has tested a type of cancer immunotherapy. Researchers have modified patients' own T-lymphocyte receptors using the CRISPR tool to direct them against specific targets on their own tumours. The results are published in the journal Nature.
Research to be published in the journal Nature identifies and characterizes the cells responsible for relapse in colon cancer. In addition, it proposes revising clinical guidelines and administering immunotherapy before surgery to try to avoid them
A study published in the journal Nature Medicine has tested a therapy based on CAR-T cells - T lymphocytes modified in the laboratory - to treat five patients with systemic lupus erythematosus who did not respond to conventional treatments. According to the study, the symptoms subsided in all of them and the improvement was maintained throughout the duration of the study.